| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9fa13c33b79ba86e25d61d5e3cee4f2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
1995-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d5ef10eb8272729e35c736c43a22396
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfdf0ea210efb5bb0c804d42533068c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cb9d166def9f1b8cce2b3b84c329018 |
| publicationDate |
1995-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0681840-A1 |
| titleOfInvention |
Use of phosphate diester for the treatment of retinal diseases |
| abstract |
A pharmaceutical composition is provided for prophylaxis and treatment of a retinal disease in a human comprising (a) a compound of the formula I:n n wherein R₁ and R₂ independently from each other denote hydrogen or methyl group, or a pharmacologically acceptable salt thereof, and (b) a pharmacologically acceptable carrier therefor. Also provided are a method for prophylaxis and treatment of a retinal disease comprising administering such a compound and a use of such a compound for preparing a pharmaceutical composition for the same purpose. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10188670-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10071030-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1861091-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1861091-A4 |
| priorityDate |
1994-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |